Select Medical Holdings Corporation Completes Spin-Off of Concentra
Select Medical Holdings Corporation Completes Spin-Off of Concentra
MECHANICSBURG, Pa., Nov. 25, 2024 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical," "we," "us," or "our") (NYSE: SEM) today announced that we have completed our previously announced distribution (the "Distribution") of 104,093,503 shares of common stock of Concentra Group Holdings Parent, Inc. ("Concentra") (NYSE: CON) owned by Select Medical Corporation ("SMC"), a wholly owned subsidiary of Select Medical, representing approximately 81.7% of the outstanding shares of Concentra's common stock. After the completion of the Distribution, Select Medical no longer owns any shares of Concentra's common stock.
宾夕法尼亚州梅卡尼克斯堡,2024年11月25日 /PRNewswire/ -- Select Medical Holdings Corporation(“Select Medical”,“我们”或“我们的”)(纽交所代码:SEM)今天宣布,我们已经完成了之前宣布的分配(“分配”)104,093,503股Concentra Group Holdings Parent, Inc.(“Concentra”)(纽交所代码:CON)的普通股,这些股份由Select Medical Corporation(“SMC”)拥有,SMC是Select Medical的全资子公司,代表了Concentra的普通股中约81.7%的流通股。在分配完成后,Select Medical不再持有Concentra的普通股。
The Distribution was made today to Select Medical's stockholders as of the close of business on the record date (the "Record Date") for the Distribution, November 18, 2024. The Distribution took place in the form of a pro rata common stock distribution to each of Select Medical's stockholder on the Record Date. Based on the shares of Select Medical's common stock outstanding as of the Record Date, Select Medical's stockholders received 0.806971 shares of Concentra's common stock for every share of Select Medical's common stock held as of the Record Date.
此次分配于2024年11月18日(“记录日期”)在营业结束时进行,针对Select Medical的股东。分配的形式是按比例向每位在记录日期持有Select Medical普通股的股东进行普通股分配。根据记录日期Select Medical的普通股的流通股数量,Select Medical的股东每持有1股Select Medical的普通股,将获得0.806971股Concentra的普通股。
No fractional shares of Concentra's common stock were distributed. Instead, Select Medical's stockholders will receive cash in lieu of any fraction of a share of Concentra's common stock that they otherwise would have received.
没有分配Concentra的普通股碎股。相反,Select Medical的股东将收到现金以替代他们本来会收到的任何Concentra普通股的碎股。
On November 19, 2024, Select Medical made available an information statement to its stockholders on the Record Date, which included details on the Distribution. The information statement is posted under the Investor Relations tab on Select Medical's website at .
在2024年11月19日,Select Medical向记录日期的股东提供了一份信息声明,内容包括有关分配的详细信息。该信息声明已发布在Select Medical网站的投资者关系选项卡下。
J.P. Morgan and Goldman Sachs acted as financial advisors to Select Medical in connection with the Distribution. Dechert LLP acted as legal advisor to Select Medical in connection with the Distribution.
摩根大通和高盛作为Select Medical在分配过程中财务顾问。Dechert LLP在分配过程中担任Select Medical的法律顾问。
About Select Medical
对于Select Medical: Shelly Eckenroth, [email protected] 或717-920-4035
Select Medical is one of the largest operators of critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States based on number of facilities. Select Medical's reportable segments include the critical illness recovery hospital segment, the rehabilitation hospital segment, the outpatient rehabilitation segment, and the Concentra segment. As of September 30, 2024, Select Medical operated 106 critical illness recovery hospitals in 29 states, 34 rehabilitation hospitals in 13 states, 1,925 outpatient rehabilitation clinics in 39 states and the District of Columbia, and 549 occupational health centers in 41 states. At September 30, 2024, Select Medical had operations in 46 states and the District of Columbia. Information about Select Medical is available at .
Select Medical是美国最大的重症康复医院、康复医院、门诊康复诊所和职业健康中心的运营商之一,按设施数量计算。Select Medical的可报告部门包括重症康复医院部门、康复医院部门、门诊康复部门和Concentra部门。截至2024年9月30日,Select Medical在29个州运营106家重症康复医院、在13个州运营34家康复医院、在39个州和哥伦比亚特区运营1,925家门诊康复诊所,以及在41个州运营549家职业健康中心。截至2024年9月30日,Select Medical在46个州和哥伦比亚特区开展业务。有关Select Medical的信息可在此获取。
This press release may contain forward-looking statements based on current management expectations. Numerous factors, including those related to market conditions and those detailed from time-to-time in Select Medical's filings with the Securities and Exchange Commission, may cause results to differ materially from those anticipated in the forward-looking statements. Many of the factors that will determine Select Medical's future results are beyond the ability of Select Medical to control or predict. These statements are subject to risks and uncertainties and, therefore, actual results may differ materially. Readers should not place undue reliance on forward-looking statements, which reflect management's views only as of the date hereof. Select Medical undertakes no obligation to revise or update any forward-looking statements, or to make any other forward-looking statements, whether as a result of new information, future events or otherwise.
本新闻稿可能包含基于当前管理层预期的前瞻性声明。许多因素,包括与市场情况相关的因素以及select medical holdings不定期在证券交易委员会的提交文件中详细说明的因素,可能导致结果与前瞻性声明中预期的结果有重大差异。许多将判断select medical holdings未来结果的因素超出了select medical holdings的控制或预测能力。这些声明面临风险和不确定性,因此,实际结果可能会有重大差异。读者不应过度依赖反映管理层截至本日期观点的前瞻性声明。select medical holdings没有义务修订或更新任何前瞻性声明,或者因新信息、未来事件或其他原因作出任何其他前瞻性声明。
Investor inquiries:
投资者查询:
Joel T. Veit
Senior Vice President and Treasurer
717-972-1100
[email protected]
Joel T. Veit
高级副总裁兼财务主管
717-972-1100
[email protected]
SOURCE Select Medical Holdings Corporation
来源:select medical holdings 公司